DEALS

Industry Buzz: The Diagnostic Market’s M&A Highlights from 1H 2017

As usual, the Big 3 of Abbott, Quest and LabCorp were the driving force of M&A activity in the diagnostics industry in the first half of 2017. Abbott Continues to Make News Each company … [Read more...]

NEWS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

After a relatively slow March and April, business has picked up noticeably in May, June and July with deal volume increasing across all transaction model sectors. Here are the highlights from the past … [Read more...]

MARKET TRENDS

Market Trends: Quest-Walmart, LabCorp- Walgreens Add Momentum to Mass Retailing of Lab Services

Mass commercialization of health care in general and laboratory services in particular is heating up with a pair of co-branding deals between leading lab chains with national retail giants. What makes … [Read more...]

NEWS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

Deal volume in May and June was noticeably higher, especially in terms of M&A activity. There was more global activity over the current than at any other point in 2017, particularly in Asia. Here … [Read more...]

NEWS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

The big story of April wasn't any particular new deal but the apparent resolution of an old one—the Abbott-Alere merger. Deal volume remained brisk, particularly in the alliance arena. But for those … [Read more...]

NEW PRODUCTS

Key Coverage Determinations and Product Developments

Although several companies secured favorable diagnostic coverage determinations in March, the big winner was Vermillion, manufacturer of the OVA1 ovarian cancer early detection test—the test covered … [Read more...]

NEWS

Diagnostic Deals: A Roundup of Mergers, Acquisitions, Alliances, Licenses and Other Major Transactions

Two-thirds of the way through the month, March has seen a relatively high volume of strategic deals but mostly of the marginal variety, particularly with regard to M&A activity. M&A The … [Read more...]

DEALS

Strategic Alliances Promote Test Access and Development

In the early months of 2017, the diagnostic industry has seen several strategic alliances develop. Among the most active companies in February so far is Quest Diagnostics which cut a deal to secure … [Read more...]

DEALS

Hologic Sells Blood Screening Business

During a slow month for diagnostic M&A activity, a noteworthy deal was Grifols's acquisition of Hologic's blood screening business. The acquired assets include a San Diego plant, development … [Read more...]

NEWSMAKERS

Veracyte Announces Big Developments

Veracyte, Inc. is a leader in developing noninvasive genomic diagnostic tests for lung cancer. And in February, Veracyte's share of this lucrative market grew significantly. Percepta Gets Thumbs Up … [Read more...]


(-0000g2)